MedTrace Logo

Oral Ketorolac for Pain Relief During IUD Insertion

NCT03031795 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2018-09-26

Study results available
· View outcomes & findings →

Summary

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID), similar to ibuprofen but it is used to treat more severe pain. Ketorolac (Trade name: Toradol) is typically used after surgical procedures. When taken orally, it should not cause sedation. The purpose of this study is to determine if oral ketorolac is effective at reducing pain during IUD placement versus a placebo tablet.

Conditions

  • Contraception

Interventions

DRUG

Ketorolac

Oral Tablet

DRUG

Placebo

Oral Tablet

Sponsors & Collaborators

  • OhioHealth

    lead OTHER

Principal Investigators

  • Michelle Crawford, MD · OhioHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-03-31
Completion
2016-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03031795 on ClinicalTrials.gov